Imfinzi IV infusion 120mg, manufactured by AstraZeneca, contains durvalumab (genetical recombination). This injectable drug (YJ code: 4291443A1023) is supplied as 120mg in 2.4mL per bottle and is indicated for the treatment of certain types of lung cancer and biliary tract cancer.
Imfinzi IV infusion 120mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).